Promising Biomarkers And New Therapeutic Targets Identified For Kidney Cancer
6/04/2012
Using blood, urine and tissue analysis of a unique mouse model, a team led by UC Davis researchers has identified several proteins as diagnostic biomarkers and potential therapeutic targets for kidney cancer. Subject to follow-up validation testing, inhibition of these proteins and several related pathways holds promise as a form of therapy to slow the growth of kidney tumors...
Dual Effect On Tumor Blood Vessels
6/04/2012
As soon as they have grown to pinhead size, tumors rely on the formation of new blood vessels - a process which is scientifically called angiogenesis. Interfering with this process (antiangiogenesis) is considered to be a promising approach in cancer medicine...
Follow-Up Care Needed For Side Effects Of Head And Neck Cancer Treatments To Be Reported
6/03/2012
New data from an Internet-based study show that patients with head and neck cancers (HNC) may be at risk for significant late effects after their treatment, but they're unlikely to discuss these and other survivorship care issues with their doctors...
Cancer Rates Expected To Increase 75% By 2030
6/01/2012
According to French researchers, the incidence of cancer is expected to increase by more than 75% by the year 2030 in developed countries, and over 90% in developing nations. The study is published Online First in the Lancet Oncology...
Cancer Problems Look Set To Nearly Double
6/01/2012
The occurrence of cancer looks set to double over the next 15+ years with researchers predicting a 75% rise in cancer incidence by 2030. In poorer countries, the number is closer to 90%. The article published in the Lancet Oncology was prepared by Dr Freddie Bray of the International Agency for Research on Cancer (IARC) in Lyon, France...
Liver Metastases And Its Prognostic Significance In Men With Metastatic Prostate Cancer
6/01/2012
Liver metastases predicts shorter overall survival in men with metastatic castration-refractory prostate cancer (mCRPC), according to data being presented at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago. (Abstract # 4655, Sunday, June 3, 8:00 AM - 12:00 PM CST, S Hall A2)...
Mesothelioma - Photodynamic Therapy Yields Longer Survival Rates
6/01/2012
Treating patients with malignant pleural mesothelioma with PDT (photodynamic therapy) alongside lung-sparing surgery appears to result in significantly longer survival rates - up to two years longer compared to other treatments, and sometimes even more, researchers from the Perelman School of Medicine, University of Pennsylvania reported in Annals of Thoracic Surgey...
First Success Of Targeted Therapy In Type Of Non-Small Cell Lung Cancer
6/01/2012
A novel compound has become the first targeted therapy to benefit patients with the most common genetic subtype of lung cancer, an international clinical trial led by scientists at Dana-Farber Cancer Institute and other institutions will report at the annual meeting of the American Society of Clinical Oncology (ASCO) June 1-5 in Chicago. Pasi A...
A "Life-And-Death" Molecule Identified On Chronic Leukemia Cells
6/01/2012
A new study has identified a life-and-death signaling role for a molecule on the surface of the immune cells involved in the most common form of chronic leukemia. The finding could lead to more effective therapy for chronic lymphocytic leukemia (CLL), an as yet incurable cancer that occurs in more than 16,000 Americans annually...
Younger Colon Cancer Patients Have Worse Prognosis At Diagnosis, Yet Better Survival
6/01/2012
Younger patients with colorectal cancer were more likely to present advanced stage tumors at diagnosis and metastasize much sooner, yet had better than or equal survival to patients 50 and older, according to data being presented at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago. (Abstract #3621, Monday, June 4, 8:00 AM - 12:00 PM CST, S Hall A2)...